Tracking 1,000+ Women's cancer journey with approved drug

NCT ID NCT05697146

Ongoing Knowledge-focused Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study observes how the already-approved cancer drug ribociclib, combined with hormone therapy, works for women with advanced breast cancer in real-world French clinics. Researchers will follow over 1,000 patients for several years to see how long the treatment controls the cancer, affects survival, and impacts quality of life. The study does not test a new treatment but collects information on how this existing treatment is used and performs outside of controlled clinical trials.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Novartis Investigative Site

Nice, Alpes Maritimes, 06189, France
Novartis Investigative Site

Marseille, Bouches Du Rhone, 13915, France
Novartis Investigative Site

Dijon, Cote D Or, 21034, France
Novartis Investigative Site

Saint-Denis, France, 97490, France
Novartis Investigative Site

Valenciennes, France, 59300, France
Novartis Investigative Site

Saint-Cloud, Hauts De Seine, 92210, France
Novartis Investigative Site

Grenoble, Isere, 38028, France
Novartis Investigative Site

Reims, Marne, 51056, France
Novartis Investigative Site

Toulon, Val De Marne, 83800, France
Novartis Investigative Site

Amiens, 80000, France
Novartis Investigative Site

Argenteuil, 95107, France
Novartis Investigative Site

Avignon, 84082, France
Novartis Investigative Site

Bayonne, 64100, France
Novartis Investigative Site

Besançon, 25030, France
Novartis Investigative Site

Béziers, 34500, France
Novartis Investigative Site

Béziers, 34535, France
Novartis Investigative Site

Brive-la-Gaillarde, 19100, France
Novartis Investigative Site

Cannes, 06414, France
Novartis Investigative Site

Carcassonne, 11000, France
Novartis Investigative Site

Chalon-sur-Saône, 71321, France
Novartis Investigative Site

Chambray-lès-Tours, 37170, France
Novartis Investigative Site

Champigny-sur-Marne, 94507, France
Novartis Investigative Site

Cherbourg, 50102, France
Novartis Investigative Site

Cholet, 49325, France
Novartis Investigative Site

Clermont-Ferrand, 63011, France
Novartis Investigative Site

Clermont-Ferrand, 63050, France
Novartis Investigative Site

Colmar, 68024, France
Novartis Investigative Site

Compiègne, 60200, France
Novartis Investigative Site

Compiègne, 60321, France
Novartis Investigative Site

Corbeil-Essonnes, 91100, France
Novartis Investigative Site

Créteil, 94000, France
Novartis Investigative Site

Dechy, 59187, France
Novartis Investigative Site

Dijon, 21000, France
Novartis Investigative Site

Dunkirk, 59240, France
Novartis Investigative Site

Eaubonne, 95600, France
Novartis Investigative Site

Fréjus, 83608, France
Novartis Investigative Site

Gleizé, 69400, France
Novartis Investigative Site

La Roche-sur-Yon, 85925, France
Novartis Investigative Site

Libourne, 33505, France
Novartis Investigative Site

Lyon, 69337, France
Novartis Investigative Site

Lyon 08, 69373, France
Novartis Investigative Site

Marseille, 13008, France
Novartis Investigative Site

Marseille, 13273, France
Novartis Investigative Site

Marseille, 13885, France
Novartis Investigative Site

Metz, 57070, France
Novartis Investigative Site

Metz, 57085, France
Novartis Investigative Site

Metz-Tessy, 74374, France
Novartis Investigative Site

Montbelliard, 25200, France
Novartis Investigative Site

Montpellier, 34070, France
Novartis Investigative Site

Nancy, 54000, France
Novartis Investigative Site

Neuilly-sur-Seine, 92200, France
Novartis Investigative Site

Niort, 79021, France
Novartis Investigative Site

Nîmes, 30029, France
Novartis Investigative Site

Osny, 95520, France
Novartis Investigative Site

Paris, 75015, France
Novartis Investigative Site

Paris, 75475, France
Novartis Investigative Site

Paris, 75970, France
Novartis Investigative Site

Perpignan, 66000, France
Novartis Investigative Site

Pierre-Bénite, 69495, France
Novartis Investigative Site

Poitiers, 86021, France
Novartis Investigative Site

Reims, 51050, France
Novartis Investigative Site

Rouen, 76038, France
Novartis Investigative Site

Rouen, 76100, France
Novartis Investigative Site

Saint-Dizier, 52100, France
Novartis Investigative Site

Saint-Etienne, 42030, France
Novartis Investigative Site

Saint-Etienne, 42100, France
Novartis Investigative Site

Saint-Nazaire, 44600, France
Novartis Investigative Site

Saint-Pierre, 97410, France
Novartis Investigative Site

Saint-Vallier, 71230, France
Novartis Investigative Site

Sarcelles, 95200, France
Novartis Investigative Site

Soyaux, 16800, France
Novartis Investigative Site

St-Malo, 35403, France
Novartis Investigative Site

St-Malo, 35404, France
Novartis Investigative Site

Suresnes, 92150, France
Novartis Investigative Site

Thionville, 57100, France
Novartis Investigative Site

Toulon La Seyne, 83056, France
Novartis Investigative Site

Toulouse, 31076, France
Novartis Investigative Site

Valence, 26000, France
Novartis Investigative Site

Vandœuvre-lès-Nancy, 54519, France
Novartis Investigative Site

Vantoux, 57070, France
Novartis Investigative Site

Villejuif, 94800, France
Novartis Investigative Site

Villeurbanne, 69100, France

Conditions

Explore the condition pages connected to this study.

BREAST CANCER